The submissions for the approval are supported by risk stratification data and a risk algorithm, which enables physicians and patients with MS to make informed decisions when considering
The distinctive formulation of ondansetron was developed leveraging MonoSol Rx’s PharmFilm technology. Company relaunched Zuplenz, the first oral soluble lingual film product cleared by FDA as a prescription
Duchesnay executive vice-president Eric Gervais said, "We are excited to enable expectant mothers within the Israeli market to have access to a proven safe and effective pharmacological treatment
Astellas is seeking approval to use Tarceva as the first-line therapy to treat patients with EGFR activating mutation-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). The
Galapagos earns a milestone payment of EUR4m from Janssen for achieving the milestone of identifying a second pre-clinical candidate. According to the deal signed between the two companies
Company expects to complete the study within six to eight months and file for FDA clearance of APPY1 in the fourth quarter of 2013. Venaxis president and CEO
Company intends to begin the construction of the new facility shortly to expand the monoclonal antibody manufacturing capacity. Amgen operations executive vice president Madhu Balachandran said the planning
The solution, VisionTracker, which features an intuitive graphical interface, comes pre-loaded with the company’s Cryo and 2D barcoded Storage Tubes and Boxes, as well as freezers, allowing quick
NanoSmart Pharmaceuticals president Dr. James Smith said the collaboration will facilitate access to UCLA’s high level of research, development and clinical resources. "Their expertise in the development of
The drug development program, funded and carried out through Spitfire Pharma, will leverage EuMederis’ EuPort technology for optimization of the pharmaceutical properties of peptide drugs. Velocity Pharmaceutical Development
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.